+ EDUCATION Abstract This scoping review directs attention to artificial intelligence–mediated informal language learning…± HEALTH Artificial intelligence (AI) is increasingly being integrated into healthcare systems and has the potential t…± HEALTH Objective This article helps neurologists understand modern approaches to diagnosing obstructive sleep apnea,…± CLIMATE Antifouling paints often contain biocides designed to inhibit biological growth, and antifouling paint partic…+ EDUCATION Generative artificial intelligence (GenAI) tools are an increasingly common resource used in the classroom an…+ HEALTH Objective Compare the effectiveness of machine learning algorithms and traditional logistic regression in pre…± HEALTH Objective Given the pivotal role of imaging in diagnosing urological cancers, artificial intelligence (AI) ha…+ HEALTH Background Traumatic cervical spinal cord injury (TCSCI) often causes severe neurological dysfunction. Accura…
TruaceTracing the truth around AIWednesday, August 5, 2026
Subscribe
Business·G Space·Evidence-backed gain·Published 2026-07-28

Cosmos Health Advances Its Technology-Driven Transformation with an AI-Enabled Subscription Platform Across B2C and B2B Channels

Digital subscription platform brings together the Company’s proprietary consumer health products across consumer (B2C) and corporate (B2B) channelsCustomers can begin through one of three paths: a free nutritionist consultation, an AI-powered assistant, or building their own packageCorporate offering supports employee wellness programs and corporate gifting through multi-recipient management, tiered volume pricing, centralized billing, and dedicated account managementFuture platform enhancements are expected to…

TRV-2026-0581JournalismPermanent record — cite & verify
Cosmos Health Advances Its Technology-Driven Transformation with an AI-Enabled Subscription Platform Across B2C and B2B Channels
The quick read

On July 27, 2026 in Chicago, Cosmos Health Inc. announced it is actively developing a flexible subscription platform for its proprietary consumer health products across B2C and B2B channels, with customer entry via nutritionist consultation, AI-powered assistant, or self-built packages, and corporate features like multi-recipient management and centralized billing.

The announcement matters because it links AI features to a direct-to-consumer health commerce model with early commercial signal from NOOR Collagen, but the platform is not yet fully launched and the AI personalization remains an expected future enhancement, leaving actual adoption, retention beyond one product, and integration of diagnostics uncertain.

Main points
  • Cosmos Health is actively developing a flexible, technology-driven subscription platform for its proprietary consumer health products across B2C and B2B channels.
  • Customers can begin through a free nutritionist consultation, an AI-powered assistant, or building their own package.
  • Corporate offering includes multi-recipient management, tiered volume pricing, centralized billing, and dedicated account management for employee wellness and gifting.
  • Platform builds on U.S. subscription launch of NOOR Collagen which has delivered an early repeat purchase rate above 60%.
Gain

Cosmos Health is actively developing an AI-enabled subscription platform that offers an AI-powered assistant entry path and builds on its NOOR Collagen launch that delivered an early repeat purchase rate above 60%.

The rundown

The Chicago announcement on July 27, 2026 describes a subscription platform covering both consumer and corporate channels. Entry paths include a free nutritionist consultation and building a custom package alongside the AI assistant. The B2B side is positioned for employee wellness programs and corporate gifting.

The company frames this as part of a broader technology-driven transformation as a vertically integrated global healthcare group trading as NASDAQ:COSM. Future enhancements are described as potential integration of at-home testing and diagnostic kits alongside AI-driven personalization.

Sources

Reader signal

How should this claim be treated?

The debate